Avoid common mistakes on your manuscript.
Recently, Lornage et al. reported a dominantly inherited myopathy associated with monoallelic variants in ACTN2, which is characterized clinically by weakness in distal and/or proximal muscles and pathologically by cores in myofibers [2]. Here, we report eight patients in three unrelated families with muscle weakness, core myopathy, and a biallelic variant in ACTN2.
Clinicopathological features of the patients are listed in Table 1. In Family 1, F1-II-6 (Fig. 1a) developed muscle weakness, predominantly in distal muscles from 32-years old. In Family 2, F2-IV-4 (Fig. 1b) had proximal muscle weakness in lower limbs and acquired left exotropia from 60-years old. The latter may be attributable to weakness of the extraocular muscles, as reported previously [2]. He had myocardial diastolic dysfunction and atrial fibrillation at 78-years-old. There was an apparent autosomal dominant family history. Other affected family members reported muscle weakness beginning in their 40 s to 60 s. In Family 3, F3-II-1 (Fig. 1c) developed limb muscle weakness from approximately 60-years-old. Muscle weakness was generalized, but there was asymmetric atrophy in the lower limbs (Fig. 2, online resource). Age at onset of these patients was similar to that of previously reported patients [3].
Muscle images showed fat replacement in the posterior compartment of the thigh, tibialis anterior, and medial head of the gastrocnemius (Fig. 1d–f). By contrast, the anterior compartment of the thigh, particularly the rectus femoris, sartorius, and gracilis, were spared. This pattern of muscle involvement is distinct from that previously described in patients with dominant variants in ACTN2 [2, 3]. Muscle pathology in the three families was similar, showing moderate to marked variation in fiber size, scattered fibers with internal nuclei, and type 1 fiber predominance (Fig. 1g-j). Furthermore, many type 1 fibers had minicore-like structures and some of them looked like lobulated fibers as reported previously [2, 3]. These structures were visible not only by NADH-tetrazolium reductase staining but also by succinate dehydrogenase and cytochrome c oxidase staining, indicating an absence of mitochondria in the cores [4] (Fig. 1k–m). Rimmed vacuoles and nemaline bodies (Table 1 and Fig. 3, online resource) were also observed, similar to previous reports [2, 3].
Whole exome sequencing identified apparently homozygous ACTN2 c.1439A > G (p.Asn480Ser) variants in affected individuals of all three families. This variant was present at extremely low frequency or not listed in public databases (Table 2, online resource). The highly conserved Asn480 residue is located in the second spectrin repeat and the pathogenicity of the p.Asn480Ser substitution was evaluated by in-silico prediction (Table 3, online resource). Although Family 2 appeared to exhibit dominant inheritance, analysis of whole exome sequencing data using XHMM demonstrated that the variant was homozygous in F2-IV-4 and F2-V-1 [1] (Fig. 4, online resource), suggesting possible pseudo-dominant inheritance pattern. Despite the complete co-segregation of the homozygosity of the variant with the disease (Fig. 1a-c), no stretches of identity-by-descent haplotypes were detected within the homozygous region, suggesting that the families do not share common ancestors (Fig. 4, online resource). Detailed experimental procedures are available online.
Cytoplasmic accumulation of TDP-43 and p62 was observed in patient muscles (F1-II-6 and F3-II-1) (Fig. 3, online resource). Actinin-2 accumulation was also observed in a similar pattern to nemaline bodies in a muscle serial section from individual F2-VI-4 (Fig. 3, online resource), suggesting that ACTN2 p.Asn480Ser contributes to abnormality of Z-lines. Electron microscopy observation revealed Z-lines with a zigzag appearance becoming jagged Z-lines (Fig. 1n, o and Fig. 5, online resource), showing core structures, similar to the findings in dominant cases reported previously [2].
Alpha-actinin-2 protein was comparatively expressed in patient’s muscle to that in control (Fig. 6, online resource). In vitro behavioral analyses of alpha-actinin-2 with p.Asn480Ser indicated that this variant does not interfere homodimerization and intracellular localization of alpha-actinin-2 (Figs. 6–9, online resource), as previously shown for dominantly inherited mutants [2]. Moreover, in the human alpha-actinin-2 crystal structure, Asn480 contributes to serve hydrogen bonds with Asn469, building to the rod structure in the second spectrin repeat and Ser substitution may alter the interaction between two helices (Fig. 10, online resource), similar to Cys487, which is mutated in dominant myopathy [3]. This may explain the reason why the symptoms of the patients in this cohort were similar especially in the age of onset, asymmetric muscle atrophy, and cardiac symptoms to those of the patients with p.Cys487Arg (Table 1) [3]. Taken together, our data indicate that this variant may have a marginal effect on the function of alpha-actinin-2, which may explain its association with late-onset, relatively mild myopathy.
References
Fromer M, Moran JL, Chambert K et al (2012) Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet 91:597–607
Lornage X, Romero NB, Grosgogeat CA et al (2019) ACTN2 mutations cause “multiple structured core disease” (MsCD). Acta Neuropathol 137:501–519
Savarese M, Palmio J, Poza JJ et al (2019) Actininopathy: a new muscular dystrophy caused by ACTN2 dominant mutations. Ann Neurol 85:899–906
Sewry CA, Wallgren-Pettersson C (2017) Myopathology in congenital myopathies. Neuropathol Appl Neurobiol 43:5–23
Acknowledgements
We would like to thank patients and their family members for their participation in this study.
Funding
This study was partly supported by Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, under Grant Numbers 3-9 (S.N.), 2-6 (S.N.), and 2-5 (I.N., S.H., A.I.); AMED, under Grant Number, JP21ek0109490h0002 (S.N., S.H., A.I, I.N.); and Joint Usage and Joint Research Programs of the Institute of Advanced Medical Sciences, Tokushima University, Grant Number 2020, 2R19.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Inoue, M., Noguchi, S., Sonehara, K. et al. A recurrent homozygous ACTN2 variant associated with core myopathy. Acta Neuropathol 142, 785–788 (2021). https://doi.org/10.1007/s00401-021-02363-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-021-02363-7